Jiangsu Hengrui Medicine
600276.SS
C$12.24
Share price
2.84%
Change (1 day)
58.39%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand
Cash on Hand as of March 2025 : C$4.59 Billion
According to Jiangsu Hengrui Medicine
's latest financial reports the company has C$4.59 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | C$3.91 B | 11.24% |
| 2022-12-31 | C$3.51 B | -6.09% |
| 2021-12-31 | C$3.74 B | 16.55% |
| 2020-12-31 | C$3.21 B | 26.68% |
| 2019-12-31 | C$2.53 B | 14.72% |
| 2018-12-31 | C$2.21 B | 168.05% |
| 2017-12-31 | C$0.82 B | -13.26% |
| 2016-12-31 | C$0.95 B | -13.47% |
| 2015-12-31 | C$1.09 B | 69.97% |
| 2014-12-31 | C$0.64 B | 69.42% |
| 2013-12-31 | C$0.38 B | 79.94% |
| 2012-12-31 | C$0.21 B | 38% |
| 2011-12-31 | C$0.15 B | 2.15% |
| 2010-12-31 | C$0.15 B | 38.07% |
| 2009-12-31 | C$0.10 B | 31.23% |
| 2008-12-31 | C$83.02 M | -28.05% |
| 2007-12-31 | C$0.11 B | 34.18% |
| 2006-12-31 | C$85.99 M | 38.12% |
| 2005-12-31 | C$62.25 M | 17.88% |
| 2004-12-31 | C$52.81 M | 67.38% |
| 2003-12-31 | C$31.55 M | -13.6% |
| 2002-12-31 | C$36.51 M | -29.98% |
| 2001-12-31 | C$52.15 M | -40.42% |
| 2000-12-31 | C$87.53 M | 410.91% |
| 1999-12-31 | C$17.13 M | 225.2% |
| 1998-12-31 | C$5.26 M | 16.93% |
| 1997-12-31 | C$4.5 M |